Hiromasa Okada
Hiroshima University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Hiromasa Okada.
Biochemical and Biophysical Research Communications | 2002
Takaharu Maruyama; Yasuhisa Miyamoto; Takao Nakamura; Yoshitaka Tamai; Hiromasa Okada; Eiji Sugiyama; Tatsuji Nakamura; Hiraku Itadani; Kenichi Tanaka
Bile acids play an essential role in the solubilization and absorption of dietary fat and lipid-soluble vitamins. Bile acids also modulate the transcription of various genes for enzymes and transport proteins for their own and cholesterol homeostasis through binding to nuclear receptors. Here we report a novel category of bile acid receptor, a membrane-type G protein-coupled receptor (GPCR), BG37. Bile acids induced rapid and dose-dependent elevation of intracellular cAMP levels in BG37-expressing cells, but not in mock-transfected cells, independently of nuclear receptor expression. The rank order of potency of various bile acids for BG37-expressing cells was different from that for the nuclear receptor-mediated response. These observations demonstrate the presence of two independent signaling pathways for bile acids; membrane-type GPCR for rapid signaling and nuclear receptors for delayed signaling. Expression of BG37 was detected in various specific tissues, suggesting its physiological role, although it remains to be further characterized.
The Journal of Antibiotics | 1998
Hiromasa Okada; Seigo Kamiya; Yasuko Shiina; Hiroaki Suwa; Masao Nagashima; Shigeru Nakajima; Haruki Shimokawa; Eiji Sugiyama; Hisao Kondo; Katsuhisa Kojiri; Hiroyuki Suda
A new antifungal antibiotic, BE-31405, was isolated from the culture broth of a fungal strain, Penicillium minioluteum F31405. BE-31405 was isolated by adsorption on high porous polymer resin (Diaion HP-20), followed by solvent extraction, precipitation and crystallization. BE-31405 showed potent growth inhibitory activity against pathogenic fungal strains such as Candida albicans, Candida glabrata and Cryptococcus neoformans, but did not show cytotoxic activity against mammalian cells such as P388 mouse leukemia. The mechanism studies indicated that BE-31405 inhibited the protein synthesis of C. albicans but not of mammalian cells.
Cancer Research | 1995
Tomoko Yoshinari; Mami Matsumoto; Hiroharu Arakawa; Hiromasa Okada; Kazuo Noguchi; Hiroyuki Suda; Akira Okura; Susumu Nishimura
The Journal of Antibiotics | 1994
Hiromasa Okada; Hajime Suzuki; Tomoko Yoshinari; Hiroharu Arakawa; Akira Okura; Hiroyuki Suda; Akihiro Yamada; Daisuke Uemura
The Journal of Antibiotics | 1986
Hiromasa Okada; Hiroyuki Mukai; Yoshio Inouye; Shoshiro Nakamura
The Journal of Antibiotics | 1985
Yoshio Inouye; Hiromasa Okada; Swapan Kumar Roy; Tadayo Miyasaka; Satoshi Hibino; Nobuo Tanaka; Shoshiro Nakamura
The Journal of Antibiotics | 1986
Yoshio Inouye; Hiromasa Okada; Jun Uno; Tadashi Arai; Shoshiro Nakamura
The Journal of Antibiotics | 1996
Hiromasa Okada; Masao Nagashima; Hajime Suzuki; Shigeru Nakajima; Katsuhisa Kojiri; Hiroyuki Suda
Archive | 1992
Masatake Kamiya; Masao Nagashima; Hiromasa Okada; Hiroyuki Suda; 裕正 岡田; 正剛 神谷; 正生 長嶋; 寛之 須田
The Journal of Antibiotics | 1987
Hiromasa Okada; Yoshio Inouye; Shoshiro Nakamura